CAMK2A and glioblastoma: We used established GBM cell lines, to test Bacopa effects as a CaMK2A phosphorylation inducer, due to the fidelity of expression of target protein of interest (CaMK2A) and the expression patterns corroborated well in GBM patient tissues (Figures 1–3).